BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3525695)

  • 1. Suppression of recurrent genital herpes simplex virus infection with recombinant alpha 2 interferon.
    Kuhls TL; Sacher J; Pineda E; Santomauro D; Wiesmeier E; Growdon WA; Bryson YJ
    J Infect Dis; 1986 Sep; 154(3):437-42. PubMed ID: 3525695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant interferon alpha 2 on clinical course of first episode genital herpes infection and subsequent recurrences.
    Mendelson J; Clecner B; Eiley S
    Genitourin Med; 1986 Apr; 62(2):97-101. PubMed ID: 3087862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of genital herpes with topically applied interferon.
    Eron LJ; Toy C; Salsitz B; Scheer RR; Wood DL; Nadler PI
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1137-9. PubMed ID: 3310870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis.
    Lebwohl M; Sacks S; Conant M; Connor J; Douglas JM; Eron L; Marlowe S; Mendelson J; Chen V; Bradstreet P
    Antiviral Res; 1992 Mar; 17(3):235-43. PubMed ID: 1567188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-interferon for labial and genital herpes virus infection].
    Glezerman M; Lunenfeld E; Doerner T; Cohen V; Sarov I; Revel M
    Harefuah; 1989 Jan; 116(2):88-90. PubMed ID: 2651244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical alpha-interferon in recurrent genital herpes simplex infection. A double-blind, placebo-controlled clinical trial.
    Shupack J; Stiller M; Knobler E; Ackerman C; Jondreau L; Kenny C
    Dermatologica; 1990; 181(2):134-8. PubMed ID: 2242782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
    Patel R; Bodsworth NJ; Woolley P; Peters B; Vejlsgaard G; Saari S; Gibb A; Robinson J
    Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon in the prevention of genital herpes recurrence.
    Eron LJ; Harvey L; Toy C; Santomauro D
    Antimicrob Agents Chemother; 1986 Oct; 30(4):608-10. PubMed ID: 3789694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte interferon-alpha in cream for the treatment of genital herpes in Asian males. A placebo-controlled, double-blind study.
    Syed TA; Cheema KM; Kahlon BM; Kahlon RC; Khayyami M; Kahlon AM; Kahlon MM
    Dermatology; 1995; 191(1):32-5. PubMed ID: 8589479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-controlled trial of topical interferon in labial and genital herpes.
    Glezerman M; Lunenfeld E; Cohen V; Sarov I; Movshovitz M; Doerner T; Shoham J; Revel M
    Lancet; 1988 Jan; 1(8578):150-2. PubMed ID: 2892991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled, patient-initiated study of topical high- and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes.
    Sacks SL; Varner TL; Davies KS; Rekart ML; Stiver HG; DeLong ER; Sellers PW
    J Infect Dis; 1990 Apr; 161(4):692-8. PubMed ID: 2156945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte interferon-alpha in a hydrophilic cream versus in a gel for the treatment of genital herpes in males: a placebo-controlled, double-blind, comparative study.
    Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
    J Dermatol; 1997 Sep; 24(9):564-8. PubMed ID: 9350101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences.
    Levin MJ; Judson FN; Eron L; Bryson YJ; Corey L; Murray M; Scheer RR
    Antimicrob Agents Chemother; 1989 May; 33(5):649-52. PubMed ID: 2751279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of interferon and placebo in the treatment of recurrent genital herpes: a double-blind trial.
    Lassus A; Bergelin I; Paloranta A; Rinne E; Eskelinen A; Säilä K
    Sex Transm Dis; 1987; 14(4):185-90. PubMed ID: 3438782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.
    Bryson YJ; Dillon M; Lovett M; Acuna G; Taylor S; Cherry JD; Johnson BL; Wiesmeier E; Growdon W; Creagh-Kirk T; Keeney R
    N Engl J Med; 1983 Apr; 308(16):916-21. PubMed ID: 6339923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical interferon cream for the treatment of herpes genitalis: a double-blind controlled trial.
    Batcheler LM; Bonham DG; Collins R; Liddell HS
    Aust N Z J Obstet Gynaecol; 1986 Aug; 26(3):239-41. PubMed ID: 3028362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of topical acyclovir in genital herpes simplex virus infections.
    Corey L; Nahmias AJ; Guinan ME; Benedetti JK; Critchlow CW; Holmes KK
    N Engl J Med; 1982 Jun; 306(22):1313-9. PubMed ID: 6280052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.